guaifenesin has been researched along with Critical Illness in 7 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pandemic of the coronavirus disease 2019 (COVID-19) has brought a global public health crisis." | 1.62 | The proteomic characteristics of airway mucus from critical ill COVID-19 patients. ( Gu, G; Li, Y; Liu, F; Liu, X; Lu, W; Luo, J; Wang, T; Xu, J; Zhang, Z; Zhao, J; Zhong, N; Zhu, A, 2021) |
| "Cimetidine treatment decreased mucus/mucin content after 3 or 6 days of treatment." | 1.37 | H2 blockers decrease gut mucus production and lead to barrier dysfunction in vitro. ( Diebel, LN; Hall-Zimmerman, L; Liberati, DM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Icard, BL | 1 |
| Rubio, E | 1 |
| Stilma, W | 1 |
| Lilien, TA | 1 |
| Bos, LD | 1 |
| Saatpoor, A | 1 |
| Elsayed, O | 1 |
| Paulus, F | 1 |
| Schultz, MJ | 1 |
| Bem, RA | 1 |
| Linssen, RS | 1 |
| Lu, W | 2 |
| Liu, X | 2 |
| Wang, T | 2 |
| Liu, F | 2 |
| Zhu, A | 2 |
| Lin, Y | 1 |
| Luo, J | 2 |
| Ye, F | 1 |
| He, J | 1 |
| Zhao, J | 2 |
| Li, Y | 3 |
| Zhong, N | 2 |
| Zhang, Z | 1 |
| Gu, G | 1 |
| Xu, J | 1 |
| Kamat, PP | 1 |
| Popler, J | 1 |
| Davis, J | 1 |
| Leong, T | 1 |
| Piland, SC | 1 |
| Simon, D | 1 |
| Harsch, A | 1 |
| Teague, WG | 1 |
| Fortenberry, JD | 1 |
| Diebel, LN | 1 |
| Liberati, DM | 1 |
| Hall-Zimmerman, L | 1 |
| Zamanian, M | 1 |
| Marini, JJ | 1 |
1 review available for guaifenesin and Critical Illness
| Article | Year |
|---|---|
The role of mucoactive agents in the mechanically ventilated patient: a review of the literature.
Topics: Acetylcysteine; Ambroxol; Critical Care; Critical Illness; Deoxyribonuclease I; Expectorants; Guaife | 2017 |
6 other studies available for guaifenesin and Critical Illness
| Article | Year |
|---|---|
Airway Mucus in Invasively Ventilated Critically Ill Patients.
Topics: Critical Illness; Humans; Mucus; Respiration, Artificial; Respiratory System; Rheology; Sputum | 2023 |
Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.
Topics: Cohort Studies; COVID-19; Critical Illness; Female; Humans; Male; Middle Aged; Mucin 5AC; Mucin-1; M | 2021 |
The proteomic characteristics of airway mucus from critical ill COVID-19 patients.
Topics: Aged; Amino Acids; Bronchoscopy; Case-Control Studies; Cholesterol; COVID-19; Critical Illness; Fema | 2021 |
Use of flexible bronchoscopy in pediatric patients receiving extracorporeal membrane oxygenation (ECMO) support.
Topics: Adolescent; Bronchoscopy; Child; Child, Preschool; Critical Illness; Extracorporeal Membrane Oxygena | 2011 |
H2 blockers decrease gut mucus production and lead to barrier dysfunction in vitro.
Topics: Bacterial Adhesion; Cimetidine; Critical Illness; Escherichia coli; Histamine H2 Antagonists; HT29 C | 2011 |
Pressure-flow signatures of central-airway mucus plugging.
Topics: Adrenal Cortex Hormones; Adult; Airway Obstruction; Airway Resistance; Anti-Bacterial Agents; Bronch | 2006 |